We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest News

News

Canadian Scientists Identify Chromosome Linked to Colorectal Cancer

Researchers at the Ontario Institute for Cancer Research have identified a genetic variation on chromosome 8 associated with colorectal cancer.
News

Roche Completes Acquisition of BioVeris

Roche Diagnostics now owns the patents for Electrochemiluminescence technology and can expand its immunochemistry into new market segments.
News

Substance in Tree Bark Could Lead to new Lung-Cancer Treatment

UT Southwestern researchers determined how a substance derived from the bark of the South American lapacho tree kills certain kinds of cancer cells.
News

Weill Cornell Medical College Team Identifies Potential new Cancer Drug Target

Weill Cornell researchers have uncovered two new potential points of vulnerability on a key cancer-promoting protein, called XIAP.
News

Abraxis BioScience Signs Licensing Agreement with University of Southern California

Abraxis exclusively licenses property portfolio designed to personalize treatment for colorectal cancer from the University of Southern California.
News

Study Suggests Breast Cancer Drug may Protect Heart

Duke researchers have opened up a new way to screen drugs for possible heart-related side effects and to develop new drugs.
News

Abbott and Caprion Extend Partnership to Discover Antibody Targets for Cancer

The extended agreement allows Abbott to retain exclusive rights to 10 targets in lung cancer identified by Caprion for up to two years.
News

QIAGEN and Digene Announce Merger Agreement

QIAGEN and Digene have announced a definitive agreement to combine the two companies to create market- and technology-leadership in molecular diagnostics.
News

Helmholtz Initiative on Systems Biology

The long-term goal of the initiative is to shed light on the causes of complex disorders and diseases and develop new approaches for treating them.
News

Bristol-Myers Squibb Awards Immunicon Research Services Agreement for Oncology Biomarker Development

The research agreement between Immunicon and Bristol-Myers Squibb involve protein and molecular targets associated with circulating tumor cells.
Advertisement